Log In
Print
BCIQ
Print
Print this Print this
 

ColoAd1

  Manage Alerts
Collapse Summary General Information
Company PsiOxus Therapeutics Ltd.
DescriptionHybrid of adenoviruses Adp3 and Ad11p
Molecular Target
Mechanism of ActionOncolytic virus
Therapeutic ModalityActive immunotherapy

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today